NCT04370691

JETi Lower Extremity Arterial Thrombosis

JET Enhanced Thrombectomy Intervention Registry - JETi Registry

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 129 (actual)
• Sponsor: Abbott Medical Devices · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The JETi Registry is a prospective, single-arm, multi-center study to collect real-world data on the safety, performance, and clinical benefits of the JETi™ Hydrodynamic Thrombectomy System (JETi System) for the treatment of acute/subacute thrombosis in the peripheral vasculature. This post-market study will register approximately 280 subjects at approximately 30 centers Globally. Subjects participating in this Registry will be followed through their 12-month follow up visit.

Conditions

• Arterial Thrombosis

Interventions

Type	Name	Description
DEVICE	JETi lower extremity arterial thrombosis	The JETi System is is a hydro-mechanical aspiration system, intended for the removal of intravascular thrombus. The system comprises of the JETi Catheter (6F or 8F), JETi Pump Set, JETi Saline Drive Unit (SDU), JETi Accessory Cart, JETi Suction tubing and JETi Non-Sterile Canister Set. The JETi System is designed to continuously aspirate thrombotic material into the catheter, where a high-pressure stream of saline within the catheter tip macerates the thrombus as it is aspirated.

Timeline

• Start date: 2020-03-06
• Primary completion: 2024-01-16
• Completion: 2024-10-09
• First posted: 2020-05-01
• Last updated: 2025-06-17
• Results posted: 2025-03-03

Locations

30 sites across 4 countries: United States, Australia, Canada, Germany